Dr. Vivek K. Narayan
Claim this profileAbramson Cancer Center of the University of Pennsylvania
Studies Prostate Cancer
Studies Adenocarcinoma
5 reported clinical trials
9 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Adenocarcinoma
BRCA1 positive
BRCA2 positive
ATM positive
Affiliated Hospitals
Clinical Trials Vivek K. Narayan is currently running
CC-94676
for Metastatic Castration-Resistant Prostate Cancer
This trial is testing a new drug called CC-94676 to see if it is safe and effective for men with advanced prostate cancer that continues to grow despite hormone-lowering treatments.
Recruiting1 award Phase 1
Web-Based Tool
for Cardiovascular Care in Prostate Cancer
The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations. The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer. The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.
Recruiting1 award N/A
More about Vivek K. Narayan
Clinical Trial Related7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Vivek K. Narayan has experience with
- Cabazitaxel
- Prednisone
- Nivolumab
- Ipilimumab
- Niraparib
- CARE-PC Web-Based Application
Breakdown of trials Vivek K. Narayan has run
Prostate Cancer
Adenocarcinoma
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vivek K. Narayan specialize in?
Vivek K. Narayan focuses on Prostate Cancer and Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Vivek K. Narayan currently recruiting for clinical trials?
Yes, Vivek K. Narayan is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Vivek K. Narayan has studied deeply?
Yes, Vivek K. Narayan has studied treatments such as Cabazitaxel, Prednisone, Nivolumab.
What is the best way to schedule an appointment with Vivek K. Narayan?
Apply for one of the trials that Vivek K. Narayan is conducting.
What is the office address of Vivek K. Narayan?
The office of Vivek K. Narayan is located at: Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Abramson Cancer Center of the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.